In summary, tissue-specific CDH17 works as a regulator of CRC SC biology by modulating LGR5 expression, Wnt signaling, MYC expression, and, therefore, stemness, and drug resistance capacities through SLC38A5 in metastatic cells (Fig. 8). This evidence concerns the gene MYC and colorectal carcinoma.